Pancreatic Lipase as a Therapeutic Target for Obesity Management: Clinical Evidence, Natural Inhibitors, and Future Perspectives
Haruna Gambo Sunday, Halimatu Sadiya Abdullahi, Okpe Kenneth & Abubakar Yahaya · Journal of Applied Life Sciences International · 2026
Inhibition of pancreatic triacylglycerol lipase remains the only mechanism by which a licensed anti-obesity medicine acts entirely within the intestinal lumen, and it continues to anchor a very large discovery literature devoted to plant-derived inhibitors. That literature has gr...
Open access
Research Article
10.9734/jalsi/2026/v29i4791